Elekta stock gains attention after analysts lift targets
Published on 08/29/2026 at 11:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Elekta stock is drawing attention on August 29, 2026, after several Swedish brokers kept buy calls and raised targets in fresh coverage. The company is Elekta AB (publ) (SE0000163628), and the latest comments land alongside a new European Investment Bank loan tied to cancer-treatment work.
Broker targets move higher
Nordea kept its buy call with a target of SEK 63, SB1 kept buy and raised to SEK 60 from SEK 59, Pareto kept buy and lifted to SEK 68 from SEK 65, and Handelsbanken kept buy with a target of SEK 70. That is a clear spread, and the highest target now stands 11.1 percent above the SEK 63 call.
The broker range matters because it frames sentiment around a stock that already trades in a tight cluster of valuation views. The same coverage shows a 17.5 percent gap between the SEK 70 high target and the SEK 59 prior level from SB1.
Loan adds context
A separate report says the EIB granted Elekta over SEK 1.1 billion for new cancer-treatments work, adding a financing angle to the name. The loan amount is larger than the SEK 70 top broker target in nominal terms, even though the two figures measure different things.
For investors, the combination of upgraded targets and a billion-krona financing headline keeps the focus on execution. A swing from SEK 59 to SEK 70 in target calls is more than cosmetic.
More on Elekta
Elekta develops radiotherapy and radiosurgery systems used in cancer care, with the company also pointing to work in neurological treatments. That product base is the backdrop for both the broker views and the EIB funding headline.
Elekta shares trade on Nasdaq Stockholm in SEK. The stock remains a Swedish mid-cap health-care name, and the latest broker targets now cluster between SEK 60 and SEK 70.
Market snapshot
As of August 29, 2026, the latest visible figures in this call center on the broker targets and the SEK 1.1 billion loan headline rather than a live quote. The key reference points are SEK 63, SEK 60, SEK 68, SEK 70, and over SEK 1.1 billion.
Company
Company: Elekta AB (publ)
ISIN: SE0000163628
Ticker: EKTA B
Exchange: Nasdaq Stockholm
Sector / Industry: Health Care / Health Care Equipment
Index membership: OMX Stockholm 30
